Adagio Medical Holdings (ADGM) Cash & Equivalents (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Cash & Equivalents data on file, last reported at $12.9 million in Q1 2026.

• Quarterly Cash & Equivalents changed 0.42% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (changed 0.42% YoY) and the FY2025 annual result came in at $17.1 million, down 16.97% from the prior year.
• Cash & Equivalents eased to $12.9 million in Q1 2026 per ADGM's latest filing, from $17.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $28.3 million in Q3 2024 and bottomed at $1.4 million in Q4 2023.
• The 4-year median for Cash & Equivalents is $12.9 million (2025), against an average of $13.3 million.
• The widest annual swing landed in 2024, when Cash & Equivalents jumped 1389.52%; it then slumped 83.39% in 2025.
• Tracing ADGM's Cash & Equivalents over 4 years: stood at $1.4 million in 2023, then jumped by 1389.52% to $20.6 million in 2024, then declined by 16.97% to $17.1 million in 2025, then declined by 24.53% to $12.9 million in 2026.
• Per Business Quant, the three latest ADGM Cash & Equivalents figures stand at $12.9 million (Q1 2026), $17.1 million (Q4 2025), and $4.7 million (Q3 2025).

Peer Comparison